leisure time -WSS

leisure time

author：fashion 2025-10-08 16:20:22 - browse：88534

The biotech company Acelyrin, which raised more than $500 million in an IPO this year, ran into its first major setback Monday as its investigational anti-inflammatory drug missed the primary goal in a pivotal clinical trial.

Acelyrin’s medicine, a subcutaneous treatment called izokibep, is meant to clear up lesions for patients with the common skin disease hidradenitis suppurativa, or HS, an inflammatory disorder that leads to abscesses and scars. But after 16 weeks of treatment, patients who received izokibep did not show significant improvements compared to those taking a placebo, failing the study’s primary endpoint.

Acelyrin’s share price fell more than 60% in after-hours trading Monday.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： As demand for Covid shots wanes, Moderna seeks its next success
Next article： Live blog: Hearing on CRISPR

Wikipedia

WSS

How to convince healthy people to buy insurance

Change Healthcare cyberattack affects 25% of CVS/Aetna insurance claims

Why Talkspace is targeting Medicare, a tricky market

Stem cell biologist probes earliest stages of human development

Change Healthcare cyberattack affects 25% of CVS/Aetna insurance claims

Fetal cell organoids grown from amniotic fluid, study finds

leisure time

leisure time

explore

State Dept. review finds Biden bears some blame for Afghanistan failures

Medicare drug price negotiation hearing pits pharma v Biden admin

State Dept. review finds Biden bears some blame for Afghanistan failures

Medicare drug price negotiation hearing pits pharma v Biden admin

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

In Gaza, a nonprofit 3D prints tourniquets and stethoscopes

Bright Health sells Medicare Advantage business to Molina

Lack of health data on LGBTQ+ people has serious consequences

Apple is now the first public company to be valued at $3 trillion

What is microchimerism and how does it affect maternal health?

leisure time

IVF doctors demand details after CooperSurgical lawsuit

The public health thinking behind the CDC’s new Covid guidance

Brain injuries and the importance of a second opinion

STAT Readout: The latest on Wegovy, Mounjaro, and Covid shots

Live blog: Hearing on CRISPR

Sarepta Duchenne therapy fails to meet primary endpoint in trial

leisure time

knowledge

Wikipedia

entertainment